Efficacy and Safety of Transcranial dIrect Current stiMulation in Multiple System Atrophy-Cerebellar Variant
Recruiting
N/A
Interventional Study
Multiple System Atrophy - Cerebellar Subtype (MSA-C)
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
At a Glance
- Age
- 40 – 90
- Sex
- Any
- Study type
- Interventional
- Purpose
- Treatment
- Participants needed
- 30 (estimated)
- Sponsor
- University of Salerno · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
This is a double-blind, randomized, sham-controlled clinical trial that aim to verify the safety and the efficacy of anodal transcranial direct current stimulation (tDCS) cerebellar symptoms in Multiple System Atrophy type C (MSA).
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Multiple system atrophy cerebellar variant according with the Movemente Disorder Society criteria (Wenning et al 2022)
* Ability to walk either indipendently or with a minimum support
Exclusion Criteria:
* Presence of electrical stimulators (for example, pacemaker, Deep Brai…
Contacts